Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Eloi Cañamero
Observed names:
Eloi Cañamero Giro,
Eloi Cañamero Giró
Institution:
Hospital de Mataró
Observed institutions:
Universitat Autònoma de Barcelona,
Josep Carreras Leukaemia Research Institute,
Maresme Health Consortium,
Institut Català d'Oncologia,
Hospital de Mataró,
Hospital Universitari Germans Trias i Pujol
show all 6
ORCID:
0000-0002-9112-2614
Observed ORCID:
0000-0002-9112-2614
OpenAlex ID:
A5026939157
New Mutations in HFE2 and TFR2 Genes Causing Non HFE-Related Hereditary Hemochromatosis
2021
·
Gonzalo Hernández
, Xenia Ferrer-Cortès
, et al.
·
Genes
·
17
PDF
Real world outcomes of momelotinib in myelofibrosis patients with anemia: results from the MOMGEMFIN study
2025
·
Lucía Pérez-Lamas
, Adrián Segura Diaz
, et al.
·
Blood Cancer Journal
·
13
PDF
Systematic review of staging bone marrow involvement in B cell lymphoma by flow cytometry
2020
·
Marc Sorigue
, Eloi Cañamero
, et al.
·
Blood Reviews
·
12
Recent developments and persisting challenges in the prevention and treatment of venous thromboembolism in patients with hematological malignancies
2020
·
Marc Sorigue
, Eloi Cañamero
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
12
Ruxolitinib in acute and chronic graft-versus-host disease: real life long-term experience in a multi-center study for adult and pediatric patients, on behalf of the GETH-TC
2024
·
Virginia Escamilla-Gómez
, Valentín García Gutiérrez
, et al.
·
Bone Marrow Transplantation
·
10
PDF
Precision medicine in follicular lymphoma: Focus on predictive biomarkers
2020
·
Marc Sorigue
, Eloi Cañamero
, et al.
·
Hematological Oncology
·
7
Real-World Outcomes of Momelotinib As an Alternative Therapy to Other JAK Inhibitors in Myelofibrosis Patients with Anemia
2024
·
Lucía Pérez-Lamas
, Adrian Segura Diaz
, et al.
·
Blood
·
3
PDF
Ruxolitinib in Acute and Chronic Graft-Versus-Host Disease: Real Life Experience in a Multi-Centre Study
2022
·
Virginia Escamilla Gomez
, Valentín García Gutiérrez
, et al.
·
Blood
·
2
Bone lesions in Erdheim-Chester disease
2020
·
Eloi Cañamero
, Ricard Pérez
, et al.
·
Medicina Clínica (English Edition)
·
2
Lesiones óseas en enfermedad de Erdheim-Chester
2019
·
Eloi Cañamero
, Ricard Pérez
, et al.
·
Medicina Clínica
·
2
Molecular predictors of anemia response to momelotinib in patients with myelofibrosis: Real-world outcomes from the momgemfin study.
2025
·
Adrian Segura Diaz
, Lucia Perez Lamas
, et al.
·
Blood
Severe Infections in Newly Diagnosed Multiple Mieloma Patients Treated Frontline with Bortezomib, Lenalidomide and Dexamethasone (VRD) in Four Reference Centers
2025
·
Andreu Casas Medina
, Itziar Carro Arostegui
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Impact of Cumulative and Relative Dose Intensity of Bortezomib, Lenalidomide, and Dexamethasone (VRD) on Depth and Duration of Response in Newly Diagnosed Multiple Myeloma (MM)
2025
·
Anna Moreno
, Itziar Carro Arostegui
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Author response for "Precision Medicine In Follicular Lymphoma. Focus On Predictive Biomarkers"
2020
·
Marc Sorigue
, Eloi Cañamero
, et al.
·
Publons reviews and discussion
Author response for "Precision Medicine In Follicular Lymphoma. Focus On Predictive Biomarkers"
2020
·
Marc Sorigue
, Eloi Cañamero
, et al.
·
Publons reviews and discussion
Impactación fecal con compresión de estructuras vecinas
2019
·
Eloi Cañamero
, Oriol Busquets
, et al.
·
Medicina Clínica Práctica
PDF
Show more works
View as search
Works count:
17
Citation count:
90
H-index:
7
I10-index:
6
Year
Topic
Type
